Austar Lifesciences Limited

HKEX:6118.HK

0.63 (HKD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q4
Operating Activities:
Net Income 5.8770-39.94441.61845.84359.43217.8720.31812.7823.9224.1693.832-3.725-28.988-25.097-6.544-12.126-3.76110.14532.44332.7517.95835.61313.393
Depreciation & Amortization 25.212017.99522.20414.33515.37214.24516.4413.39913.08811.5083.554.0233.6054.3096.2184.6585.344.613.2894.0273.0992.6161.527
Deferred Income Tax 000000000000000000000000
Stock Based Compensation 000000000000000000000000
Change In Working Capital 000-200.6620-526.1870-79.8390-52.1280-233.1970-4.1450-15.6150-40.7030-43.846027.781-120.0431.098
Accounts Receivables 000-293.7210-259.10706.5840-16.2710-89.6450-10.5220-0.6530-17.1750-49.426031.569-95.6860
Change In Inventory 00024.5980-222.690-47.2740-43.8950-54.60604.3760-26.5140-6.27405.2150-2.011-23.649-6.415
Change In Accounts Payables 00000000000000000000032.562-7.5130
Other Working Capital 00068.4610-44.390-39.14908.0380-88.94602.001011.5520-17.25400.3650-1.777-0.7087.513
Other Non Cash Items -11.550-42.881141.456-102.72369.249-253.43104.068-34.94487.272-30.038194.648-46.72979.694-35.54939.086-46.139129.664-43.76928.284-121.348-1.689106.0721.835
Operating Cash Flow 19.5390-64.834.616-42.542-82.136-21.31560.987-8.76352.154-14.361-31.167-46.43150.166-56.33723.145-53.60790.54-29.01420.17-84.57147.14924.25817.852
Investing Activities:
Investments In Property Plant And Equipment -5.5790-34.536-33.622-83.705-57.695-42.876-24.107-2.433-7.838-5.887-1.19-3.996-7.084-2.013-7.405-3.609-14.1740-4.61-7.159-5.601-5.448-2.946
Acquisitions Net 000000000-7.45100000000000-6.2746.1390
Purchases Of Investments 000000000000000000000-2.5-18.75-18.75
Sales Maturities Of Investments 0000000000000000000008.77412.61112.611
Other Investing Activites 17.92909.17-40.0794.263-34.008199.6012.997-36.263-0.412-0.499-34.159-0.1531.5815.021-26.941-21.74110.973-21.7555.73524.748-33.5770.0779.085
Investing Cash Flow 12.350-25.366-73.701-79.442-91.703156.725-21.11-38.696-15.701-6.386-35.349-4.14624.4973.008-34.346-25.35-3.201-21.7551.12517.589-39.178-5.371-9.085
Financing Activities:
Debt Repayment -46.986098.67705.97605.9760-6.2450-3.1880000000000000
Common Stock Issued 00000000000000000000085.24600
Common Stock Repurchased 00000000000000000000-0.001-78.74900
Dividends Paid 000000000000000000-20.255-5.9890-1.49700
Other Financing Activities -9.0210-16.30722.67496.65154.967-1.5941.643-0.911-10.584-6.9225.218-0.778-6.587.414-0.331-15.75-1.182-0.847315.134-20.3726.5075.2442.907
Financing Cash Flow -56.007082.3722.674102.62754.9674.3821.643-7.156-10.584-10.115.218-0.778-6.587.414-0.331-15.75-1.182-21.102309.145-20.3735.015.2442.907
Other Information:
Effect Of Forex Changes On Cash 0.33600.0931.234-0.289-0.6790.257-0.2840.244-0.164-0.223-0.02-0.1880.2980.502-0.255-0.537-3.409-0.118-0.162-0.011-0.1040.093-2.398
Net Change In Cash -23.7820-7.733-45.177-19.646-119.551140.04941.236-54.37125.705-31.08-61.318-51.54368.381-45.413-11.787-95.24482.748-71.989330.278-87.366-31.179101.1829.275
Cash At End Of Period 139.983125.891125.891133.624178.801198.447317.998177.949136.713191.084165.379196.459257.777309.32240.939286.352298.139393.383310.635382.62452.34695.656126.83534.928